Locations:
Search IconSearch
February 16, 2022/Neurosciences/Podcast

Understanding the Role and Future of Peripheral Nerve Neurosurgery (Podcast)

Growing subspecialty offers options for patients with a host of nerve injuries and diseases

Peripheral nerve neurosurgery is a subspecialty that’s little understood. However, it can be game-changing for people with acute nerve injuries, entrapment neuropathies, benign nerve tumors and other nerve disorders.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“The best part of my job is working directly with patients and helping them restore function and helping take away pain, which for some of my patients really changes their lives,” says Megan Jack, MD, PhD, a peripheral nerve neurosurgeon and researcher in Cleveland Clinic’s Neuromuscular Center. “It gets them back to work. It gets them back to enjoying the life they had.”

In the most recent episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Jack talks about the value of peripheral nerve neurosurgery within the nerve injury treatment landscape. She delves into:

  • Conditions that are best suited to peripheral nerve neurosurgery
  • The importance of a multidisciplinary approach to treating patients with nerve injuries
  • The slow pace of nerve regeneration and potential surgical options to speed it up
  • A move toward surgeries that restore sensation as well as improve motor skills
  • Research into new peripheral nerve surgeries, medications and other treatments

Click the podcast player above to listen to the 21-minute episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™. After listening to the podcast, you can claim your credit here.

Excerpt from the episode

Podcast host Glen Stevens, DO, PhD: This is a loaded question and has a lot of caveats, but who do we intervene on?

Megan Jack, MD: I think early referral to a peripheral nerve neurosurgeon [is important]. One of the unfortunate things that I’ve seen throughout the field is that nerves take a long time to recover. So we watch our patients very closely. But as that continues, it moves them more and more toward being outside that surgical window.

Advertisement

Typically, laceration is something we like to repair within three days, but that’s pretty rare. For most patients, we like to intervene anywhere from three to six months if we haven’t seen recovery either clinically or on an EMG or functionally. And so for those patients, it’s sort of a race against time to where you’re giving them enough time to recover on their own if they’re going to recover, but you don’t want to go so far that the de-innervation changes that occur in the muscle — those more permanent losses of muscle — makes it so you can’t functionally get back any of that muscle weakness that’s occurred even after surgery.

It’s sort of threading the appropriate needle to intervene, when necessary, but doing it in the appropriate time. I always say, refer your patients early to us. We like to get a good exam early on. That way we’re able to follow the patient to determine if they are recovering properly. Take Parsonage-Turner syndrome, for example. Almost 80% of those patients get better on their own, but it’s the 20% of patients who don’t for whom we want to make sure we intervene early enough that we can actually change their outcomes.

Advertisement

Related Articles

William Clifton, MD, against a decorative background
November 4, 2024/Neurosciences/Podcast
Adult Idiopathic Scoliosis: Essentials of Diagnosis and Treatment (Podcast)

Early intervention yields the best outcomes, but surgery can benefit older patients as well

Creative illustration of a brain
October 16, 2024/Neurosciences/Podcast
Diagnosing Atypical Parkinsonian Disorders (Podcast)

Patient history plays a key role in identifying the condition

dr. daniel ontaneda against a decorative background
October 2, 2024/Neurosciences/Podcast
Takeaways From the New Diagnostic Criteria for Multiple Sclerosis (Podcast)

A co-author explains some of the key McDonald criteria revisions

Dr. Imad Najm against a decorative background
September 16, 2024/Neurosciences/Podcast
Temporal Lobe Epilepsy and the Potential of Gene Therapy (Podcast)

Investigational gene approaches offer hope for a therapeutically challenging condition

alison stout, DO, against a decorative backdrop
August 9, 2024/Neurosciences/Podcast
Evaluation and Interventional Treatment of Axial Lumbar Back Pain (Podcast)

This common condition remains tough to work up and diagnose, and treatment options are limited

Dr. Amy Kunchok against decorative background
July 16, 2024/Neurosciences/Podcast
What to Know About Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) (Podcast)

It’s time to get familiar with this emerging demyelinating disorder

receptor activity for myasthenia gravis medications
July 3, 2024/Neurosciences/Podcast
Myasthenia Gravis: Unmet Needs and Efforts to Address Them (Podcast)

An overview of associated antibodies, therapies for antibody-positive disease and the outlook for atypical forms of MG

adult female figure suffering headache
June 17, 2024/Neurosciences/Podcast
Migraine Relief: Providing Preventive and Abortive Therapies (Podcast)

A close look at the growing array of options for episodic and chronic migraine

Ad